The tumour suppressor function of SMAD2/3 in the endometrium was found to be mediated by the PI3K/PTEN/AKT signalling pathway, which has an important role in regulating epithelial cell homeostasis and interfering with the effect of both pathways on endometrial carcinogenesis. Here, SMAD2 is linked to neoplasm.